EDITORS EMULSION 1st Oct 2018

For over 10 years at least, a battle has been raging on whether science or commerce dictates a company’s decision to market an FDC. With there being multiple levels of scrutiny, the end to this discussion seemed nigh and there was a ban on 328 drugs. But with pro-health groups saying that FDCs account for half the domestic drugs market and half that segment is irrational, the battle on combination drugs seems far from over. Get an insight into this interesting article in PSM India capsules.

Government is working on policies and laws to better the healthcare sector like bringing in an Indian standardization of medical devices or constituting committees to check the safety and efficacy of FDCs. Read more such news under drug laws and policy injections while going through articles under Pharma injections such as on drug firms retaining their brand names for new medicines or diagnosis of diseases to get cheaper and more accurate.

While you review the list on new drugs approved till date under the section named Drug Dopes, catch up on spurious drugs being unearthed in India and the world over in National and Global Injections respectively.

We constantly endeavour not only to collate important information from the health and medicine world but also to create a connect with consumers all over. We welcome articles and write ups from our readers and are glad to feature them under the section titled Subscriber’s Symptoms. This issue features a contribution by Mr.Parmeshwar Rao from Maharashtra on “Current Trends in Detection of Falsified Medicines.” Mark your calendar with the upcoming events listed in our newsletter and remember to take your laughter dose in the end.

Do not hesitate to mail your comments on this newsletter to help us improve further. We appreciate your support and trust in us and are happy to have you as our loyal reader. Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@patientsafetyaccess.org .

You may find our previous issues on our website patientsafetyaccess.org or in the NEWS ARCHIVE section of every  issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook .

Stay Healthy. Stay Safe.

Pooja Mishra Khaitan

Editor-in-Chief,

The Prescription